FINWIRES · TerminalLIVE
FINWIRES

Update: Identiv Shares Fall 31% After Company Agrees to Sell IoT Business Assets to Trackonomy

By

(Updates to add latest stock movement in lead and headline and adds analysts downgrades in paragraph 2)

Identiv (INVE) shares fall 31% in Thursday trading after it said Wednesday it agreed to sell its IoT business operating assets and its Thai subsidiary to Trackonomy Systems in exchange for $50 million of Trackonomy preferred equity and a $25 million cash contribution.

Lake Street and Craig Hallum downgraded the stock to buy from hold.

Under the definitive agreement, Identiv will sell its IoT assets, including its German research and development center and its Thai subsidiary. The cash contribution is intended to support integration efforts and capital expenditures, the company said.

Identiv and Trackonomy also entered into a partnership framework agreement to collaborate on software opportunities leveraging Trackonomy's physical AI platform.

The sale is expected to close in Q3 or early Q4, subject to customary closing conditions, including Identiv stockholder approval.

Identiv said it plans to remain publicly listed under the ticker symbol "INVE". However, the Identiv name and brand are included in the sale, and the company will adopt a new name after the transaction closes.

Price: $2.44, Change: $-1.25, Percent Change: -33.88%

Related Articles

Wire

Arovella Therapeutics Secures Ethics Approval for First-in-Human Study of Blood Cancer Drug Candidate

Arovella Therapeutics (ASX:ALA) received ethics approval from The Alfred and Bellberry Human Research Ethics Committees to begin its phase 1 first-in-human clinical trial of ALA-101 drug candidate, a chimeric antigen receptor invariant natural killer T (CAR-iNKT) cell therapy for patients with relapsed or refractory lymphomas and leukemias, according to a Thursday Australian bourse filing.The trial is expected to involve up to seven clinical sites across Australia and New Zealand, the filing said. It will evaluate the safety, tolerability, and preliminary anti-tumor activity of ALA-101.The company remains on track to begin first patient dosing in the September quarter.Arovella Therapeutics' shares fell past 1% in recent trading on Thursday and earlier hit their lowest since September 2023.

ASX:ALA
Wire

Update: Tourism Holdings Receives Additional Non-Binding Takeover Offer From Unnamed 'Credible Strategic' Buyer; Shares Over Two-Year High

(Updates to add stock movement in the headline and the last paragraph)Tourism Holdings (ASX:THL, NZE:THL) received an additional non-binding indicative offer from an unnamed "credible strategic" buyer to acquire 100% of the company at a proposed price of NZ$3.30 to NZ$3.40 per share, according to a Thursday filing with the New Zealand and Australian bourses.The proposal is subject to customary conditions, including due diligence, board approval, regulatory and third-party consents, and unanimous board recommendation, subject to standard fiduciary carve-outs, per the filing.The company has allowed the bidder to conduct due diligence under a confidentiality agreement while emphasizing that no decision has been made and there is no assurance that a transaction will proceed, the filing said.The company is also engaged in discussions with the BGH consortium on a similar confidentiality agreement to support due diligence, the filing added.The company's shares on the New Zealand bourse rose 12% in Thursday trading and earlier reached their highest level since April 2024, while Australian shares gained 11%.

ASX:THLNZE:THL
Wire

Lockheed Martin Wins Up to $35 Billion Contract to Expand US Missile Defense Production

Lockheed Martin (LMT) won a seven-year US government contract worth up to $35 billion to quadruple production of its Terminal High Altitude Area Defense interceptors.The award is one of the first major multiyear procurement contracts under the Pentagon's new acquisition strategy, Lockheed Martin said Wednesday in a statement.The contract implements a THAAD framework agreement signed in January and is intended to support long-term production scaling and strengthen the missile-defense industrial base for the US and its allies, the company said.Lockheed Martin shares rose 0.9% in after-hours trading.

$LMT